Stocks · Health care · Pharmaceutical Preparations

Akebia Therapeutics, Inc.

AKBA Clue Score38

United States Fiscal year ends December CIK 0001517022 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net buying

Bought (12 mo)

$86.59K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$962.96K

$962.96K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 16 sales

Net

−$876.37K

+$86.59K against sales at will